Clinical trial
A Pivotal USA Randomized, Evaluator-blinded, Active-controlled, Multi-center, Split-face Comparison Study of Emervel Classic Lidocaine Versus Juvederm® Ultra in the Treatment of Moderate to Severe Facial Wrinkle Folds
NCT01205048 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pivotal USA Randomized, Evaluator-blinded, Active-controlled, Multi-center, Split-face Comparison Study of Emervel Classic Lidocaine Versus Juvederm® Ultra in the Treatment of Moderate to Severe Facial Wrinkle Folds
- Lead sponsor
- Galderma R&D
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2010
- Completion date
- January 19, 2012
- Enrollment
- 171 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
skin wrinkling